Giuseppe | Gene Regulation Epigenetics | Outstanding Scientist Award

Published on by Cell Biologist

Prof. Dr. Giuseppe | Gene Regulation Epigenetics | Outstanding Scientist Award

Istituto di Ricerche Farmacologiche Mario Negri | Italy

Dr. Giuseppe Remuzzi, an Italian physician and researcher with long career in nephrology and internal medicine, obtained his M.D. cum laude from the University of Pavia in 1974, followed by specializations in Laboratory and Clinical Hematology (1977) and in Clinical Nephrology (cum laude, 1980) from University of Milan. He held positions as Resident Fellow in Internal Medicine at Ospedale Briolini, Gazzaniga; then Assistant Professor and later Associate Professor in Nephrology and Dialysis at Ospedali Riuniti, Bergamo; he also did research fellowships in the U.K. at Babraham (Cambridge) and Guy’s Hospital Medical School (London). His research broadly spans kidney disease, clinical nephrology, molecular‐and pathophysiological mechanisms of renal injury, and translational studies. According to Google Scholar, Remuzzi has an h-index of 232, has published thousands of scholarly documents, and has received on the order of ~448,630 citations.  Other sources such as Research.com report his Medicine discipline D-index ~209 with ~282,315 citations in Medicine alone. Throughout his career he has contributed numerous papers in high‐impact journals, guiding advances in diagnostics, treatments, and understanding of kidney function and disease, and remains a leading figure in Italian and international nephrology research.

Profiles: Orcid | Scopus

Featured Publications:

Perico, L., Casiraghi, F., Benigni, A., & Remuzzi, G. (2025). Is there a place for engineered immune cell therapies in autoimmune diseases? Trends in Molecular Medicine. Advance online publication.

Anandh, U., Anders, H.-J., Bacchetta, J., Johnson, D. W., Luyckx, V., Remuzzi, G., Rodriguez-Iturbe, B., Susztak, K., Tuttle, K., & Yanagita, M. (2025). Two decades of nephrology research: Progress and future challenges. Nature Reviews Nephrology. Advance online publication.

Ghaddar, M., Caravaca-Fontán, F., Praga, M., Fernández-Juárez, G., Lomax-Browne, H. J., Cook, H. T., Daina, E., Noris, M., Remuzzi, G., Induruwage, D., & colleagues. (2025). Clinical and histologic predictors of kidney outcomes in C3 glomerulopathy and idiopathic membranoproliferative GN. Clinical Journal of the American Society of Nephrology. Advance online publication.

Pezzotta, A., Perico, L., Morigi, M., Corna, D., Locatelli, M., Zoja, C., Benigni, A., Remuzzi, G., Imberti, B., & colleagues. (2025). Correction: Low nephron number induced by maternal protein restriction is prevented by nicotinamide riboside supplementation depending on sirtuin 3 activation. Cells, 14(17), 1328.

Zoccali, C., Provenzano, P. F., Tripepi, G., Carrara, F., Mallamaci, F., Perna, A., Delanaye, P., Ruggenenti, P., & Remuzzi, G. (2025). Reliability of GFR estimated by creatinine-based formulas in moderate-to-severe proteinuria. Clinical Journal of the American Society of Nephrology. Advance online publication.

Zoccali, C., Mallamaci, F., Lightstone, L., Jha, V., Pollock, C., Tuttle, K., Kotanko, P., Wiecek, A., Anders, H.-J., Remuzzi, G., & colleagues. (2024). A new era in the science and care of kidney diseases. Nature Reviews Nephrology, 20(7), 439–453.

Evgeny Deforzh | Cancer | Best Researcher Award

Published on by Cell Biologist

Dr. Evgeny Deforzh | Cancer | Best Researcher Award

Brigham and Women’s Hospital, Harvard University | United States

Dr. Evgeny Deforzh is a molecular biologist whose work focuses on the regulation of RNA, microRNAs, chromatin dynamics, and their roles in cancer and neurological disease. After earning his B.S. and M.S. in Biology from Saint Petersburg State University and a Ph.D. in Molecular Biology from Paris‑Saclay University, he completed postdoctoral research as a Research Fellow and subsequently served as Instructor in Neurology at Brigham & Women’s Hospital. His peer‑reviewed contributions include insights into how WEE1 regulators switch roles in cell cycle control, protection of cyclin mRNAs from translational repression, the impact of glioblastoma‑derived extracellular vesicles on astrocyte transformation, and the nuclear modulation of splicing by oncogenic microRNAs. More recently, his work has elucidated promoter/enhancer RNA regulation of super‑enhancers, and miRNA pathways as therapeutic targets in gliomas and meningiomas. To date, Dr. Deforzh has published ~15–20 independent original research articles (first‑, co‑first, or senior‑author) with many additional co‐authored papers. His publications have been cited in the literature ~800‑1,200 times, giving him an approximate h‑index of 12–15. His research has advanced understanding of RNA regulatory networks in cancer and offers potential translational pathways for diagnostics and therapy.

Profiles: Google Scholar | Scopus

Featured Publications:

Zeng, A., Wei, Z., Rabinovsky, R., Jun, H. J., El Fatimy, R., Deforzh, E., & Arora, R. (2020). Glioblastoma-derived extracellular vesicles facilitate transformation of astrocytes via reprogramming oncogenic metabolism. iScience, 23(8), 101420.

Deforzh, E., Uhlmann, E. J., Das, E., Galitsyna, A., Arora, R., Saravanan, H., … (2022). Promoter and enhancer RNAs regulate chromatin reorganization and activation of miR-10b/HOXD locus, and neoplastic transformation in glioma. Molecular Cell, 82(10), 1894–1908.e5.

El Fatimy, R., Zhang, Y., Deforzh, E., Ramadas, M., Saravanan, H., Wei, Z., … (2022). A nuclear function for an oncogenic microRNA as a modulator of snRNA and splicing. Molecular Cancer, 21(1), 17.

Poller, W., Sahoo, S., Hajjar, R., Landmesser, U., & Krichevsky, A. M. (2023). Exploration of the noncoding genome for human-specific therapeutic targets—Recent insights at molecular and cellular level. Cells, 12(22), 2660.

Deforzh, E., Vargas, T. R., Kropp, J., Vandamme, M., Pinna, G., & Polesskaya, A. (2016). IMP-3 protects the mRNAs of cyclins D1 and D3 from GW182/AGO2-dependent translational repression. International Journal of Oncology, 49(6), 2578–2588.

Kratassiouk, G., Pritchard, L. L., Cuvellier, S., Vislovukh, A., Meng, Q., … (2016). The WEE1 regulators CPEB1 and miR-15b switch from inhibitor to activators at G2/M. Cell Cycle, 15(5), 667–677.

Xinghua Pan | Single Cell and Spatial Omics | Excellence in Research Award

Published on by Cell Biologist

Prof. Xinghua Pan | Single Cell and Spatial Omics | Excellence in Research Award

Macau University of Science and Technology | China

Professor Xinghua (Victor) Pan, PhD, MD, is a distinguished researcher in the fields of single-cell technology, spatial omics, genome medicine, regenerative biology, and cancer heterogeneity. Currently serving as a professor at the Precision Regenerative Medicine Research Centre (PRMRC), Macau University of Science and Technology (MUST), he is also affiliated with the State Key Laboratory of Quality Research in Chinese Medicine. Dr. Pan earned his MD and MS degrees from Southern Medical University and completed his PhD in genetics at Fudan University under the mentorship of renowned geneticist Dr. CC Tan. His interdisciplinary research integrates cutting-edge single-cell and multi-omics platforms to investigate tumor microenvironments, stemness, and disease mechanisms at cellular resolution. Dr. Pan has authored over 280 peer-reviewed publications, with a current h-index of 48, more than 9,200 citations, and his work spans high-impact journals such as Nature, Nature Communications, Advanced Science, Nucleic Acids Research, and Cancer Research. He is frequently recognized as a corresponding or co-corresponding author in key studies advancing genomic technologies and translational applications in precision medicine. His contributions continue to shape the landscape of cellular and molecular research globally.

Profiles: Google Scholar | Orcid

Featured Publications:

Zhang, Y., Lu, Y., Mai, L., Wen, Z., Dai, M., Xu, S., Lin, X., Luo, Y., Qiu, Y., Chen, Y., Dong, Z., Chen, C., Meng, W., Luo, X., Lin, G., Tam, P. K. H., & Pan, X. (2025). Dynamic heterogeneity towards drug resistance in AML cells is primarily driven by epigenomic mechanism unveiled by multi-omics analysis. Journal of Advanced Research. Advance online publication.

Su, H., Zhou, X., Lin, G., Luo, C., Meng, W., Lv, C., Chen, Y., Wen, Z., Li, X., Wu, Y., Xiao, C., Yang, J., Lu, J., Luo, X., Hong, X., Chen, Y., Tam, P. K. H., Li, C., Sun, H., & Pan, X. (2025). Deciphering the oncogenic landscape of hepatocytes through integrated single-nucleus and bulk RNA-seq of hepatocellular carcinoma. Advanced Science, 12, e2412944.

Huang, Y., Wang, Q., Zhou, W., Jiang, Y., He, K., Huang, W., Feng, Y., Wu, H., Liu, L., Pan, Y., Huang, Y., Chen, Z., Li, W., Huang, Y., Lin, G., Zhang, Y., Ren, Y., Xu, K., Yu, Y., … Hu, Y. (2024). Prenatal p25-activated Cdk5 induces pituitary tumorigenesis through MCM2 phosphorylation-mediated cell proliferation. Neoplasia, 57, 101054.

Gao, J., Wu, Y., Yu, J., Qiu, Y., Yi, T., Luo, C., Zhang, J., Lu, G., Li, X., Xiong, F., Wu, X., & Pan, X. (2024). Impact of genomic and epigenomic alterations of multigene on a multicancer pedigree. Cancer Medicine, 13(13), e7394.

Chen, F., Zhang, K., Wang, M., He, Z., Yu, B., Wang, X., Pan, X., Luo, Y., Xu, S., Lau, J. T. Y., Han, C., Shi, Y., Sun, Y. E., Li, S., & Hu, Y. P. (2024). VEGF-FGF signaling activates quiescent CD63(+) liver stem cells to proliferate and differentiate. Advanced Science, 11, e2308711.

Mai, L., Wen, Z., Zhang, Y., Gao, Y., Lin, G., Lian, Z., Yang, X., Zhou, J., Lin, X., Luo, C., Peng, W., Chen, C., Peng, J., Liu, D., Marjani, S. L., Tao, Q., Cui, Y., Zhang, J., Wu, X., Weissman, S. M., & Pan, X. (2023). Shortcut barcoding and early pooling for scalable multiplex single-cell reduced-representation CpG methylation sequencing at single nucleotide resolution. Nucleic Acids Research, 51, e108.

Rachel Foster | Microbial Oceanography | Best Researcher Award

Published on by Cell Biologist

Prof. Rachel Foster | Microbial Oceanography | Best Researcher Award

Stockholm University | Sweden

Rachel A. Foster is a leading researcher in microbial oceanography, with significant contributions to the study of planktonic symbioses, particularly those involving nitrogen-fixing cyanobacteria and diatoms. Her research focuses on the evolution, function, and genomic innovations of symbiotic microorganisms that drive key biogeochemical cycles in marine ecosystems. Foster has pioneered single-cell approaches, including mass spectrometry imaging and heterologous gene expression, to uncover molecular interactions between symbiotic partners. She has secured major national and international grants, including from the Swedish Research Council, SciLifeLab, Formas, and the Wallenberg Foundation, supporting both basic and applied research. She has published 71 peer-reviewed works, including 3 book chapters, with 31 as first or senior author, and her work has been cited 5,944 times. Her current h-index is 40, demonstrating both the depth and influence of her scholarship. Her editorial contributions include serving as Specialty Co-Chief Editor for Frontiers in Aquatic Microbiology. Foster’s recent work includes high-impact publications in Current Biology, The ISME Journal, and PNAS Nexus, as well as openly shared datasets. Through multidisciplinary collaborations across Europe, she continues to shape our understanding of microbial symbioses and their evolutionary significance in the ocean.

Profiles: Scopus | Orcid

Featured Publications:

Grujcic, V., Mehrshad, M., Vigil-Stenman, T., Lundin, D., & Foster, R. A. (2025). Stepwise genome evolution from a facultative symbiont to an endosymbiont in the N2-fixing diatom-Richelia symbioses. Current Biology.

Nieves-Morión, M., Romero-García, R., Bardi, S., López-Maury, L., Hagemann, M., Flores, E., & Foster, R. A. (2025). Retention of a SulP-family bicarbonate transporter in a periplasmic N2-fixing cyanobacterial endosymbiont of an open ocean diatom. The ISME Journal.

Foster, R. A. (2025, April 27). Molecular markers for Richelia symbionts of open ocean diatom symbioses [Dataset]. figshare.

Grujcic, V., Mehrshad, M., Vigil-Stenman, C. T., Lundin, D., & Foster, R. A. (2025, March 25). The path to dependence: Stepwise genome evolution from a facultative symbiont to an endosymbiont in the N2-fixing diatom-Richelia symbioses [Preprint]. bioRxiv.

Nieves-Morión, M., Romero-García, R., Bardi, S., López-Maury, L., Hagemann, M., Flores, E., & Foster, R. A. (2024, January 10). Using gene complementation to identify a SulP-family bicarbonate transporter in an N2-fixing cyanobacterial endosymbiont of an open ocean diatom [Preprint]. bioRxiv.

Nieves-Morión, M., Camargo, S., Bardi, S., Ruiz, M. T., Flores, E., Foster, R. A., & Bayer, E. (2023). Heterologous expression of genes from a cyanobacterial endosymbiont highlights substrate exchanges with its diatom host. PNAS Nexus.

Kelly Bosak | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Dr. Kelly Bosak | Stem Cell Research | Best Researcher Award

University of Kansas Medical Center | United States

Dr. Kelly A. Bosak, PhD, APRN, ANP-BC, FHFSA, is a tenured Associate Professor at the University of Kansas Medical Center and a nationally recognized expert in heart failure care, nursing science, and implementation research. With a strong background in advanced practice nursing and nursing administration, Dr. Bosak has made significant contributions to interdisciplinary research focused on improving clinical outcomes in cardiology, rural health, and chronic disease management. Her peer-reviewed work spans high-impact journals such as The Journal of Cardiac Failure, Implementation Science, and The Journal for Nurse Practitioners, reflecting her leadership in both clinical practice and academic scholarship. Dr. Bosak has authored or co-authored over 30 peer-reviewed publications, with a Scopus h-index of 10, over 450 citations, and 32 documents indexed in major databases. She has played a pivotal role in national reports from the Heart Failure Society of America and led multiple implementation science projects aimed at integrating evidence-based interventions into routine care. Her current research emphasizes digital health innovation and workforce development in underserved communities. Dr. Bosak’s interdisciplinary collaborations and translational research continue to shape evidence-based practice and policy in cardiovascular nursing and advanced practice nursing education.

Profiles: Google Scholar | Scopus

Featured Publications:

  • “Return on Investment of a Nurse Practitioner Fellowship Program”

  • “Interprofessional Education for Improving Workforce Capacity to Treat COPD and Long COVID in Rural Communities”

  • “Shared Decision Making for the Pulmonary Artery Monitoring Device for Patients with Heart Failure”

  • “Implementation of a SmartPhrase for Exercise in the Electronic Health Record for Individuals with Heart Failure”

  • “Implementing a Standardized Workflow for Early Detection of Steroid-Induced Hyperglycemia in Allogeneic Stem Cell Transplant Recipients: A Quality Improvement Project”

  • “Team Science”

  • “Ceramides as Novel Biomarkers of Cardiometabolic Conditions”

  • “Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America”

  • “Heart Failure Epidemiology and Outcomes Statistics, A Report of the Heart Failure Society of America”

  • “Implementation Mapping and Concept Mapping to Explore Guideline Implementation in the Heart Failure Clinic”

  • “Coordinating Resources for a Hybrid Effectiveness and Implementation Trial Across an Integrated Digital Network for Heart Failure”

  • “Creating a Standardized Approach to Program Evaluation in a Magnet Recognized Pediatric Hospital System”

 

 

 

Ann-Kathrin Eisfeld | Molecular Profiles | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Ann-Kathrin Eisfeld | Molecular Profiles | Best Researcher Award

The Ohio State University | United States

Dr. Ann-Kathrin Eisfeld is an internationally recognized physician-scientist and Associate Professor with Tenure in the Division of Hematology at The Ohio State University, where she also serves as Director of the Clara D. Bloomfield Center for Leukemia Outcomes Research. Her research focuses on the molecular and genetic underpinnings of acute myeloid leukemia (AML), with a particular emphasis on translational applications that improve patient outcomes. Dr. Eisfeld has published extensively in high-impact journals such as Nature, Leukemia, Blood, and Cell Stem Cell, contributing significantly to our understanding of leukemia biology, clonal evolution, and treatment resistance. she has authored over 100 peer-reviewed scientific publications, with an h-index of 38, more than 6,500 citations, and has led or co-led multiple collaborative studies within national consortia such as the Alliance for Clinical Trials in Oncology. Her work has identified critical biomarkers and therapeutic targets in AML, including insights into TP53 mutations, FLT3 alterations, and resistance mechanisms to venetoclax. Recognized for her integration of clinical insight with cutting-edge genomics, Dr. Eisfeld is a leading voice in precision oncology and leukemia research, shaping the future of individualized treatment strategies through both clinical innovation and scientific discovery.

Profile: Scopus

Featured Publications:

“Highly elevated serum hepcidin in patients with acute myeloid leukemia prior to and after allogeneic hematopoietic cell transplantation: Does this protect from excessive parenchymal iron loading?”

“Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia”

“miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia”

“Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia”

“Kinetics of iron removal by phlebotomy in patients with iron overload after allogeneic hematopoietic cell transplantation”

“inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations”

“Clinical Role of microRNAs in Cytogenetically Normal Acute Myeloid Leukemia: miR-155 Upregulation Independently Identifies High-Risk Patients”

“In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline”

“A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia”

Emine Mine Soylu | Plant Pathology | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Emine Mine Soylu | Plant Pathology | Best Researcher Award

Hatay Mustafa Kemal University | Turkey

Prof. Dr. Emine Mine Soylu is a prominent academic in the field of plant pathology, with a career spanning over three decades dedicated to plant protection, host-pathogen interactions, and disease management strategies in crops. She began her professional journey as a Research Assistant at Akdeniz University and has since contributed significantly to scientific research through both experimental studies and scholarly publications. Her work is widely recognized, with a particular focus on the identification and control of fungal and bacterial diseases in economically important plants. Prof. Soylu has published 54 scientific documents in internationally refereed journals and has amassed a total of 3,749 citations, reflecting the substantial impact of her work in the field. Her h-index is 25, indicating consistent and high-quality contributions to science over the years. Her research includes first reports of various plant diseases in Türkiye and in-depth studies on disease resistance mechanisms and biochemical plant responses. Prof. Soylu’s contributions continue to shape the future of sustainable agriculture and plant health, and her collaborations extend across national and international scientific communities. Her scholarly output and citation metrics demonstrate her strong influence in the field of phytopathology and plant-microbe interactions.

Profiles: Google Scholar | Scopus |  Orcid

Featured Publications:

  • “Preliminary Characterization of Race-Specific Elicitors From Peronospora parasitica and Its Ability to Elicit Phenolic Accumulation in Arabidopsis”

  • “First Report of Downy Leaf Spot of Walnuts Caused by Microstroma juglandis in Turkey”

  • “Induction of Disease Resistance by the Plant Activator, Acibenzolar-S-methyl (ASM), Against Bacterial Canker (Clavibacter michiganensis subsp. michiganensis) in Tomato Seedlings”

  • “First Report of Powdery Mildew Caused by Erysiphe heraclei on Dill (Anethum graveolens) in Turkey”

  • “Light and Electron Microscopy of the Compatible Interaction Between Arabidopsis and the Downy Mildew Pathogen Peronospora parasitica”

  • “Induction of Defence Related Enzymes and Resistance by the Plant Activator Acibenzolar-S-methyl in Tomato Seedlings Against Bacterial Canker Caused by Clavibacter michiganensis subsp. michiganensis”

  • “First Report of Cercospora Leaf Spot on Swiss Chard Caused by Cercospora beticola in Turkey”

  • “First Report of Phloeospora Leaf Spot on Mulberry Caused by Phloeospora maculans (=Cylindrosporium maculans) in the Eastern Mediterranean Region of Turkey”

  • “Induction of Disease Resistance and Antioxidant Enzymes by Acibenzolar-S-methyl Against Bacterial Canker (Clavibacter michiganensis subsp. michiganensis) in Tomato”

  • “First Report of Powdery Mildew Caused by Podosphaera phaseoli (syn. Sphaerotheca phaseoli) on Cowpea (Vigna sinensis) in Turkey”

 

 

 

 

 

 

 

 

 

 

Paola Leone | Neuronal Cell Biology | Pioneer Researcher Award

Published on by Cell Biologist

Prof. Dr. Paola Leone | Neuronal Cell Biology | Pioneer Researcher Award

Rowan-Virtua SOM and Virtua Health College of Medicine and Life Sciences of Rowan University | United States

Dr. Paola Leone is a neuroscientist and cell biologist whose work focuses on pediatric white matter diseases, mechanisms of myelination, and gene/cell‐based therapies to repair white matter pathology. After completing a doctoral degree in Neuroscience at the University of Padua (Italy), she undertook a post‑doctoral fellowship in Behavioral Neurobiology at Concordia University, Montreal, where early work included studies on dopamine receptors and opioid interaction in reward pathways. Over subsequent decades, her research has expanded to include using viral vector models, evaluating gene expression in glial and neuronal interactions, and metabolic demands in neurological disease models such as Alzheimer’s and leukodystrophies. According to institutional metrics, her department (Cell Biology at Rowan University) shows ~6,735 citations and an h‑index of 44 across roughly 176 articles (plus reviews and other contributions). Roan University These figures reflect both leadership in publications and influence in the neuroscience/cell biology community. Her scholarly contributions have significantly advanced understanding of neuron‑glia energetics, genetic regulation of myelination, and translational strategies for repair in white matter disease.

Profile: Scopus

Featured Publications:

  • “Blockade of D1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning”

  • “5HT3 receptor antagonists block morphine and nicotine- but not amphetamine-induced reward”

  • “SCH 23390 blocks drug-conditioned place preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?”

  • “Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release as measured by in vivo microdialysis”

  • “Intrahippocampal injection of a HSV-1 vector expressing GluR6 induces spontaneous limbic seizures and CA1 and CA3 hyperexcitability”

  • “Differential involvement of ventral tegmental Mu, Delta and Kappa opioid receptors in modulation of basal mesolimbic dopamine release: In vivo microdialysis studies”

  • “Ventral mesencephalic & opioid are involved in modulation of basal mesolimbic dopamine neurotransmission: an anatomical localization study”

  • “Striatal tissue preparation facilitates early sampling in microdialysis and reveals an index of neuronal damage”

  • “Mesolimbic dopamine neurotransmission is increased by administration of µ-opioid receptor antagonists”

  • “Direct measurement of extracellular lactate in the human hippocampus during spontaneous seizures”

Rizwan Khan | Diabetic Neuropathy | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Rizwan Khan | Diabetic Neuropathy | Best Researcher Award

Aligarh Muslim University | India

Dr. Rizwan Hasan Khan is a distinguished professor at the Interdisciplinary Biotechnology Unit of Aligarh Muslim University, specializing in biophysical chemistry and molecular interactions related to protein aggregation and therapeutic drug design. With a Ph.D. awarded focused on lectins, Dr. Khan has significantly contributed to understanding protein fibrillation, aggregation mechanisms, and their inhibition, particularly in relation to amyloid diseases and antimicrobial resistance. His research encompasses the biophysical characterization of proteins, the impact of toxins and drugs on protein behavior, and the identification of novel inhibitors through computational and experimental approaches. Dr. Khan’s prolific output includes over 16 peer-reviewed research and review articles published in reputed journals such as Biophysical Chemistry, Archives of Biochemistry and Biophysics, and Cell Reports, reflecting interdisciplinary expertise in biotechnology, biochemistry, and drug discovery. His work has attracted citations highlighting its influence in the fields of amyloid research and therapeutic development. Dr. Khan maintains an h-index indicative of sustained scholarly impact, underscoring his role as a leading researcher in molecular biophysics and pharmacology. His research continues to advance knowledge in combating protein aggregation disorders and antimicrobial resistance, contributing valuable insights into novel drug candidates and molecular mechanisms.

Profiles: Google Scholar | Scopus

Featured Publications:

  • “Inhibition of nucleation and disruption of amyloid fibrillation in human lysozyme aggregation by a potent Cu (II) flufenamate chemotherapeutic drug candidate”

  • “Ponceau 4R induces aggregation in human serum albumin and morin acts as an anti-aggregating agent against dye induced aggregates”

  • “Hippuric acid, a uremic toxin, binds to aggregation prone region of human lysozyme and potentiates the fibrillation: A biophysical insight”

  • “Identification of potential inhibitors of Ubiquitin carboxyl-terminal hydrolase 21 from repurposed drugs: Implications in anticancer therapeutics”

  • “Loss of Neurofibromin Induces Inflammatory Macrophage Phenotypic Switch and Retinal Neovascularization via GLUT1 Activation”

  • “Employing spectroscopic, calorimetric and structural bioinformatics approaches to decipher the binding mechanism of mangiferin with human transferrin”

  • “Interaction of Esculetin with Alpha-2-Macroglobulin: Biochemical and Biophysical Approaches”

  • “Utilizing non-β-lactam antibiotics to combat antimicrobial resistance by targeting multiple virulence factors of Pseudomonas aeruginosa”

  • “Strategies for inhibiting amyloid fibrillation: Current status and future prospects”

  • “Assessing the role of Berberine as an inhibitor of advanced glycation end products (AGEs) formation using in vitro and molecular interaction studies”

Bao-Min Yao | Microbial Cell Biology | Best Researcher Award

Published on by Cell Biologist

Mr. Bao-Min Yao | Microbial Cell Biology | Best Researcher Award

Research Center for Eco-Environmental Sciences | China

Bao-Min Yao is a distinguished researcher affiliated with multiple prestigious institutions, including the School of Environmental & Resource Sciences at Shanxi University, the State Key Laboratory of Urban and Regional Ecology at the Research Center for Eco-Environmental Sciences of the Chinese Academy of Sciences, the University of Chinese Academy of Sciences, the School of Life Sciences at Hebei University, and the Municipal Engineering Department at Beijing University of Technology. His interdisciplinary work spans environmental science, urban ecology, and civil engineering, reflecting a comprehensive approach to addressing complex ecological and environmental challenges. Over the course of his career, Bao-Min Yao has authored a substantial number of scientific publications, contributing significantly to the advancement of knowledge in his fields of expertise. His research output has been widely recognized, as evidenced by a strong citation record and a notable h-index, indicating both the productivity and the impact of his work within the scientific community. His contributions encompass studies on ecological sustainability, resource management, and environmental protection, underpinning policy and technological innovation. Bao-Min Yao’s dedication to research excellence is further demonstrated through his collaborative engagements across institutions, fostering interdisciplinary dialogues and innovations. His scholarly influence is reflected in the volume of citations his work has garnered, underscoring his role as a leading voice in environmental and ecological research.

Profile: Scopus

Featured Publications:

“Soil pH and bacterial diversity synergistically regulate trace element transfer and accumulation in soil-rice systems”